NEW DELHI: The S&P BSE Sensex plunged over 300 points in trade on Tuesday, but that didn't bother traders to cherry pick quality stocks at lower... ...http://economictimes.indiatimes.com/markets/stocks/news/individual-stocks-outperform-sensex-over-400-stocks-hit-52-week-high-on-bse/articleshow/42627329.cms
India is among the world's fastest-growing pharma markets, accounting for 25 per cent of the world's generic drug market. The issues of delivering... ...http://www.business-standard.com/article/opinion/vaibhav-choukse-sweetheart-deals-that-hurt-consumers-114091501332_1.html
California-based Gilead is set to stir the pot as it forges India-based alliances on its Hepatitis C drug sofosbuvir. Multi-company agreements on... ...http://www.thehindubusinessline.com/companies/gileads-local-alliances-on-hepatitis-c-drug-sovaldi-set-for-a-rough-ride/article6412522.ece?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS_Syndication
In addition to sound fundamentals, buying interest from institutional investors — foreign institutional investors and mutual funds — also... ...http://www.thehindubusinessline.com/features/investment-world/fiis-mfs-take-different-paths/article6410081.ece?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS_Syndication
Rahul Arora, CEO at Nirmal Bang Institutional Equities is of the view that one can buy Natco Pharma at Rs 1500. ...http://www.moneycontrol.com/news/stocks-views/buy-natco-pharma-rahul-arora_1177436.html
Erlonat (Erlotinib) is a Kinase...